The Center for Innovative Drug Discovery
provides capabilities and core services to support biomedical research related to drug discovery.
About the CIDD
The Center for Innovative Drug Discovery (CIDD), a joint venture between The University of Texas at San Antonio and UT Health San Antonio, is composed of four facilities: a High-Throughput Screening (HTS) Facility and a Computer Automated Drug Design (CADD) Core Facility located at UT Health San Antonio and a Medicinal Chemistry and Synthesis Core Facility and a Preclinical Pharmacology Core Facility at UTSA.
The ultimate intent of the CIDD is to provide a diverse array of core facilities and expertise to facilitate the translation of basic scientific discoveries into tangible pre-clinical candidate drugs that can be further developed into clinical therapies for human disease.
The mission of the Center for Innovative Drug Discovery is to catalyze collaborations with investigators by providing high-quality, industry-level services and expertise related to small molecule drug discovery and pre-clinical development.
The center accomplishes the mission by:
– Bolstering multidisciplinary collaborations among investigators in the fields of structure biology, computer-aided drug discovery, medicinal chemistry, and pharmacology.
– Providing cutting-edge scientific facilities and equipment.
The CIDD has the capability of target identification & validation, assay development, virtual & high-throughput screening, and optimization of hits/leads aided by computational modeling, structural biology and medicinal chemistry in close collaboration with the Biomolecular NMR, X-ray Crystallography, Cryo-Electron Microscopy and Protein Structure Biology Cores at the UTHSA.
Below is a brief description of the facilities and resources at the CIDD: